Oncoclinicas Saudi Arabia

Oncoclínicas&Co is the leading oncology group in Latin America and a global leader in precision medicine, clinical trials, and integrated oncology solutions. In 2024, Oncoclínicas&Co and Al Faisaliah Group announced a joint venture to enter the Saudia Arabian market, establishing Oncoclinics. This partnership brings Oncoclínicas&Co’s expertise, state-of-the-art treatment modalities, and patient-centric tailored cancer care to the Kingdom, and will leverage Al Faisaliah Group’s extensive local know-how and experience in healthcare investment and operations. Oncoclinics is redefining oncology care and setting a new standard for oncology excellence in Saudi Arabia by establishing the first hub-and-spoke network of specialized outpatient centers, starting in the heart of its capital, Riyadh. This model ensures that patients receive world-class care close to home, supported by advanced diagnostics, digital health solutions, and seamless coordination. Oncoclinics is set to revolutionize cancer care by reducing wait times, enhancing survival rates, and delivering holistic, multidisciplinary support.